New device predicts dangerous drops in blood pressure after heart surgery

NCT ID NCT05964374

Completed Disease control Sponsor: University of Calgary Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a goal-directed therapy system that uses a special monitor and algorithm to predict low blood pressure in 100 adults after heart surgery. The device helped guide doctors on when to give fluids or medications to keep blood pressure stable. The goal was to see if this approach works better than standard care in the intensive care unit.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Goal-directed therapy using HemoSphere monitor, Acumen transducer, and Hypotension Prediction Index algorithm
What this could lead to: If successful, this approach could help doctors better manage blood pressure after heart surgery, potentially reducing complications and speeding recovery.
What could go wrong: This is a small pilot study with only 100 participants, so results may not apply to all patients. The device is a tool, not a cure, and its benefit over standard care is not yet proven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SURGERY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

SURGERY

Contacts and locations

Locations

Foothills Medical Centre

Calgary, Alberta, T2N2T9, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.